T2 Biosystems In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More News items for the week of Jan. 23, 2023. Earnings Roundup: HTG Molecular, T2 Biosystems, Co-Diagnostics, Biocept, Oncocyte, OpGen The genomic and diagnostics firms posted quarterly financial results late this week. HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects The funding is being provided to 10 groups through the LymeX Diagnostics Prize initiative, which was launched in late 2020 by theHHS- and Cohen Foundation-backed Lyme Innovation Accelerator. T2 Biosystems Regains Compliance with Nasdaq Listing Requirement The company had previously been informed that its shares failed to meet the exchange's $1 minimum bid price requirement. Canaccord Downgrades T2 Biosystems to Hold The investment bank cited a soft Q3 outlook, slower-than-expected pipeline progress, and capital and liquidity concerns raised in the company's preliminary quarterly results. Oct 12, 2022 T2 Biosystems Effects Reverse Stock Split, Reports 50 Percent Drop in Preliminary Q3 Revenues Sep 29, 2022 BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option Sep 23, 2022 In Brief This Week: Thermo Fisher Scientific, Exact Sciences, T2 Biosystems, Helix, More Aug 30, 2022 T2 Biosystems Regains Nasdaq Listing Requirements Aug 16, 2022 Earnings Roundup: Lucira Health, T2 Biosystems, Interpace Biosciences Jul 15, 2022 In Brief This Week: Centogene, Novacyt, T2 Biosystems, Inotiv, Oxford Nanopore, More Jul 6, 2022 T2 Biosystems Reports Preliminary Drop in Q2 Revenues, Cuts Workforce Jun 10, 2022 In Brief This Week: T2 Biosystems, HTG, Thermo Fisher, Dante Genomics, OriCiro Genomics, More May 27, 2022 In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More May 5, 2022 T2 Bio Q1 Revenues Inch up 3 Percent; Firm Warned by Nasdaq of Listing Non-Compliance Apr 1, 2022 T2 Biosystems Exercises BARDA Contract Option Valued at $4.4M Feb 18, 2022 T2 Biosystems Q4 Revenues Down 10 Percent, Beat Wall Street Expectations Jan 11, 2022 Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results Nov 4, 2021 T2 Biosystems Q3 Revenues Jump 42 Percent Aug 5, 2021 T2 Biosystems Q2 Revenues More Than Double, Beat Estimates May 7, 2021 T2 Biosystems Advancing Pipeline, Accelerating Instrument Placement Strategy Premium May 6, 2021 T2 Biosystems Q1 Revenues Nearly Triple Mar 4, 2021 T2 Biosystems Q4 Revenues Jump 152 Percent on Strong Product Sales Jan 27, 2021 T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates Nov 4, 2020 T2 Biosystems Q3 Revenues Triple, Beat Estimates Load More Breaking News Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Metastatic Tumor Subtypes Found With Expression Profiling GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement Sherlock Biosciences to Acquire Sense Biodetection The Scan Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals. Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival. CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system. Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.